Hilde Elst
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- NF-κB Signaling Pathways
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cancer Cells and Metastasis
- Cytokine Signaling Pathways and Interactions
Papers in
- Oncology 7
- Cancer Cells and Metastasis 5
-
- Cancer Genomics and Diagnostics 2
- Breast Cancer Treatment Studies 2
- NF-κB Signaling Pathways 1
- Co-authors
- Peter A. van Dam (7 shared papers)Peter Vermeulen (6 shared papers)Steven Van Laere (5 shared papers)Ilse Van der Auwera (4 shared papers)Luc Dirix (6 shared papers)Ina Benoy (5 shared papers)Hermine H. Maes (2 shared papers)P. Huget (2 shared papers)
- Journals
- Clinical Cancer Research (2 papers)British Journal of Cancer (2 papers)Clinical Breast Cancer (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Breast Cancer Research (1 paper)
- Partner nations
- BelgiumGermanyUnited Kingdom
In The Last Decade
Hilde Elst
10 papers receiving 451 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 200
- Oncology 267
- Molecular Biology 143
- Pulmonary and Respiratory Medicine 46
- Otorhinolaryngology 6
Countries citing papers authored by Hilde Elst
This map shows the geographic impact of Hilde Elst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilde Elst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilde Elst more than expected).
Fields of papers citing papers by Hilde Elst
This network shows the impact of papers produced by Hilde Elst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilde Elst. The network helps show where Hilde Elst may publish in the future.
Co-authors
The 25 scholars most cited alongside Hilde Elst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 145 | |
| 2 | 2006 | 88 | |
| 3 | 2009 | 75 | |
| 4 | 2005 | 29 | |
| 5 | Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation. | 1991 | 29 |
| 6 | 2006 | 25 | |
| 7 | 2008 | 24 | |
| 8 | 2006 | 24 | |
| 9 | 1993 | 13 | |
| 10 | 2009 | 6 |
About Hilde Elst
Hilde Elst is a scholar working on Oncology, Cancer Research, Molecular Biology, Surgery and Pulmonary and Respiratory Medicine, having authored 10 papers that have together received 458 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (2 papers), Breast Cancer Treatment Studies (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Epigenetics and DNA Methylation (1 paper), NF-κB Signaling Pathways (1 paper) and Radiation Effects and Dosimetry (1 paper). The work is most often cited by research in Cancer Research (200 citations), Oncology (267 citations), Molecular Biology (143 citations), Pulmonary and Respiratory Medicine (46 citations) and Otorhinolaryngology (6 citations). Hilde Elst has collaborated with scholars based in Belgium, Germany and United Kingdom. Frequent co-authors include Peter A. van Dam, Peter Vermeulen, Steven Van Laere, Ilse Van der Auwera, Luc Dirix, Ina Benoy, Hermine H. Maes, P. Huget, Eric A. Van Marck and Luc Dirix. Their work appears in journals such as Clinical Cancer Research, British Journal of Cancer, Clinical Breast Cancer, Clinical Chemistry and Laboratory Medicine (CCLM) and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.